Volume No. : 5
Issue No. : 4
Year : 2013
ISSN Print : 0975-4407
ISSN Online : 2321-5836
Registration
Allready Registrered
Click to Login
|
Email ID Not Available
|
Address:
|
Punita R. Maurya*, Yadunath M. Joshi, Vilasrao J. Kadam.
Department of Pharmacology, BharatiVidyapeeth’s College of Pharmacy, Sector-8, C.B.D. Belapur, NaviMumbai-400614, Maharashtra, India.
*Corresponding Author
|
|
DOI No: Not Available
ABSTRACT:
Bronchial asthma is chronic inflammatory disorder of the respiratory tract, characterised by increased airway hyper responsiveness to provocative exposures and episodic airflow obstruction. It is an increasing global health burden, especially in the Western world. As we learn more about the cause, pathophysiology, phenotypes and genetics of asthma; treatments will become available to ensure adequate asthma control; even may help in development and implementation of an optimal strategy for its management and prevention. This review article summarizes current pharmacological approaches for the management of asthma, including an update on the definition, types, cause, appropriate diagnostic evaluation, and pathogenesis of bronchial asthma.
|
KEYWORDS:
Bronchial asthma, spirometer, hyper-responsiveness, pharmacological management, inhaled corticosteroids, Omalizumab.
|
Cite:
Punita R Maurya, Yadunath M Joshi, Vilasrao J Kadam.
A Review on Bronchial asthma. Research J. Pharmacology and Pharmacodynamics. 2013; 5(4). 257-265.
|
 [View HTML]
 [View PDF]
|
|